Indicate the antipsychotic drug, which is a phenothiazine aliphatic derivative:

Questions 265

ATI RN

ATI RN Test Bank

Pharmacology Across the Lifespan Questions

Question 1 of 5

Indicate the antipsychotic drug, which is a phenothiazine aliphatic derivative:

Correct Answer: C

Rationale: In pharmacology across the lifespan, understanding the classification and properties of antipsychotic drugs is crucial for safe and effective patient care. In this question, the correct answer is C) Chlorpromazine, which is a phenothiazine aliphatic derivative. Chlorpromazine is a classic first-generation antipsychotic that belongs to the phenothiazine class, specifically an aliphatic derivative. This drug acts by blocking dopamine receptors in the brain, making it effective in managing psychotic symptoms. Option A, Thiothixene, is a thioxanthene derivative, not a phenothiazine aliphatic derivative. Option B, Risperidone, is a second-generation antipsychotic belonging to the benzisoxazole class. Option D, Clozapine, is an atypical antipsychotic and does not fall under the phenothiazine aliphatic derivative category. Educationally, understanding the differences in antipsychotic drug classes is essential for healthcare professionals to make informed decisions regarding drug selection, dosing, and monitoring for adverse effects. Knowledge of drug classifications also aids in predicting potential drug interactions and side effects, contributing to safer medication management in patients across the lifespan.

Question 2 of 5

The principal mechanism of action of antidepressant agents is:

Correct Answer: C

Rationale: The correct answer is C) Blocking epinephrine or serotonin reuptake pumps. Antidepressant agents primarily work by blocking the reuptake pumps responsible for the removal of serotonin and/or norepinephrine from the synaptic cleft. By inhibiting this reuptake process, these medications increase the concentration of these neurotransmitters in the synaptic space, leading to improved mood and alleviation of depressive symptoms. Option A) Stabilization of dopamine and beta-adrenergic receptors is incorrect because antidepressants do not primarily target these receptors in their mechanism of action. Option B) Inhibition of the storage of serotonin and epinephrine in the vesicles of presynaptic nerve endings is incorrect as it does not accurately depict the main mechanism of action of antidepressants. Option D) Stimulation of alpha2-norepinephrine receptors is incorrect as this is not the primary mechanism through which antidepressant medications exert their effects. Understanding the mechanisms of action of pharmacological agents is crucial for healthcare professionals, particularly in the field of pharmacology. Knowing how antidepressants work can guide healthcare providers in making informed decisions regarding drug selection, dosing, and monitoring for their patients with depression across the lifespan. This knowledge also helps in explaining treatment plans to patients, ensuring better adherence and outcomes.

Question 3 of 5

Block of which type of Monoamine Oxydase might be more selective for depression?

Correct Answer: A

Rationale: In pharmacology, the selective inhibition of monoamine oxidase (MAO) is crucial in the treatment of depression. MAO-A primarily metabolizes serotonin, norepinephrine, and dopamine, while MAO-B mainly metabolizes phenylethylamine and dopamine. The correct answer is A) MAO-A because its inhibition leads to increased levels of serotonin, norepinephrine, and dopamine, which are neurotransmitters implicated in depression. Selective inhibition of MAO-A avoids potential side effects associated with the non-selective inhibition of both MAO-A and MAO-B. Option B) MAO-B is incorrect because its selective inhibition is more relevant in the treatment of Parkinson's disease rather than depression. Option C) Both MAO-A and MAO-B is incorrect as non-selective inhibition may lead to adverse effects like hypertensive crisis. Option D) MAO-C is a distractor as MAO-C does not exist. Understanding the selectivity of MAO inhibitors is crucial for prescribing the appropriate medication based on the patient's condition. This knowledge is essential for healthcare providers to ensure effective and safe treatment for patients with depression across different stages of life.

Question 4 of 5

Which of the following tricyclic and heterocyclic agents has the least sedation?

Correct Answer: A

Rationale: In pharmacology across the lifespan, understanding the sedative effects of tricyclic and heterocyclic antidepressants is crucial for safe prescribing practices. In this scenario, the correct answer is A) Protriptyline as it has the least sedation among the options provided. Protriptyline is a secondary amine tricyclic antidepressant known for its relatively lower sedative effects compared to other drugs in the same class. This is due to its more potent norepinephrine reuptake inhibition properties and shorter half-life, which contribute to its reduced sedative potential. Now, let's analyze why the other options are incorrect: - B) Trazodone is known for its sedative properties and is often used to treat insomnia due to its strong sedative effect. - C) Amitriptyline is a tertiary amine tricyclic antidepressant that is well-known for its sedative effects, making it unsuitable for patients who need to avoid sedation. - D) Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA) known for its sedative properties, particularly at lower doses. Educationally, understanding the varying sedative effects of different tricyclic and heterocyclic antidepressants is essential for healthcare professionals to make informed decisions when selecting medications for patients across the lifespan. This knowledge helps in tailoring treatment plans to individual patient needs, considering factors such as sedation, tolerability, and efficacy.

Question 5 of 5

Anxiolytic agents should:

Correct Answer: B

Rationale: Anxiolytic agents are medications designed to reduce anxiety and induce a calming effect in individuals. The correct answer, B, states that anxiolytic agents should reduce anxiety and exert a calming effect. This is because anxiolytics work by targeting neurotransmitters in the brain to decrease excessive neuronal activity that leads to anxiety symptoms. By doing so, these medications help individuals manage their anxiety and feel calmer without causing sedation or sleepiness. Option A, relieving pain, is incorrect because anxiolytic agents are not primarily used for pain relief. Pain management typically involves analgesic medications specifically designed to target pain pathways in the body, not anxiety. Option C, improving mood and behavior in patients with psychotic symptoms, is incorrect as anxiolytic agents are not indicated for treating psychotic symptoms. Psychotic disorders require antipsychotic medications that target different neurotransmitter systems to address hallucinations, delusions, and other symptoms associated with psychosis. Option D, producing drowsiness and encouraging sleep, is incorrect because anxiolytic agents are not meant to induce drowsiness or promote sleep as their primary goal. While some anxiolytics may have a sedative effect, their main function is to reduce anxiety and promote a sense of calmness without causing excessive sedation. In an educational context, understanding the specific actions and indications of anxiolytic agents is crucial for healthcare professionals to appropriately prescribe these medications and educate patients on their use. Knowing the intended effects of anxiolytics can help ensure their proper utilization in managing anxiety disorders across the lifespan.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions